• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • Samples
    • MRI Images
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Access

EPAD offers a way of accessing the data, samples and image data collected during the EPAD Longitudinal Cohort Study (LCS), to academic researchers, institutions and companies from all over the world. EPAD data is shared through a secure online Workspace. To access the data, you will need to make an online request via the EPAD LCS Research Access Process (ERAP).

Datasets available

  • EPAD LCS V500.0 (published 19th May 2019) – doi:10.34688/epadlcs_v500.0_19.05.10
  • EPAD LCS V1500.0 (published 29th November 2019) – doi:10.34688/epadlcs_v1500.0_19.11.29
  • EPAD LCS V500.1 (published 4th May 2020) – doi:10.34688/epadlcs_v500.1_20.04.29
  • EPAD LCS V.IMI (published 30th October 2020) – doi:10.34688/epadlcs_v.imi_20.10.30

To learn what data and associated metadata is available in the EPAD data releases before you apply, please refer to the relevant release’s Data Information Pack in the Supporting Media section below.

Join an Existing Research Project

Before making an application of your own, have a look at the projects already being undertaken.

If you would like to join one of these projects and collaborate with the team, email us on the contact form at the bottom of this page, quoting the Application ID.

How do I apply?

Applications are made through a system called Wizehive. We have also provided a comprehensive video walkthrough of the application process.

  1. To set up an account with Wizehive, you need to provide the required information in the link on this page.
  2. Once this is received and checked by the ERAP Administration, you will receive an email explaining how to login to Wizehive.
    • You only have to do this once, subsequent applications can be done directly in your Wizehive account.
  3. Next, complete your research access application, taking care to complete all sections of the form.
    • Make sure you press “Submit” when your application is complete.

Notes on use of Wizehive:

  • All applications must be submitted through Wizehive.
  • Use the link that was provided to you by email from the EPAD Research Access Administration to access the Wizehive portal.
  • The email address that you supplied in step 1 will be your User Name.
  • You can reset your password using the Forgot Password link on the portal sign-in page.
  • Use the Homepage to manage your applications by following the instructions on the screen.
  • If you have any other issues accessing the Wizehive portal then you can contact us via the form below.

What happens next?

For data access only, your application will be processed within 2-3 business days.

For access to data with corresponding biological samples or MRI DICOM data, your application will be forwarded to the relevant Research Access Committee for consideration/approval. You will be contacted by the chair of the committee within 7-10 business days.

How do I access my data?

You and your team will then receive login details for the Aridhia DRE platform. Your data will be hosted here in a secure, online Workspace containing analytical tools for you and your team to utilise in your research. You can find more information on using the platform in the Aridhia DRE knowledge base.

Begin the application process

How do I complete and submit an application?

  1. As an EPAD researcher you will now have a Wizehive account that you can use to complete and submit an application. Use the link that was provided to you by email from the EPAD Research Access Administration to access the Wizehive portal. (The email address that you supplied in your first application will be your User Name).
  2. Use the Homepage to manage your applications by following the instructions on the screen.
  3. Make sure you press “Submit” when your application is complete.
  4. You can reset your password using the Forgot Password link on the portal sign-in page.
  5. If you have any other issues accessing the Wizehive portal then you can contact us via the form below.

Complete and submit an application


If you have any technical difficulties accessing Aridhia DRE, please don’t hesitate in contacting us by filling in the contact form below.

Supporting media

Application Process Video

Protocols

  • EPAD Protocol Version 5.0

V500.0

  • Data Information Pack (V500.0)

V1500.0

  • Data Information Pack (V1500.0)

V500.1

  • Data Information Pack (V500.1)

V.IMI

  • Data Information Pack (V.IMI)

Supplementary resources

  • WizeHive Guide, May 2019
  • ERAP Webinar Tutorial, September 2019
  • EPAD RAVE eCRF
  • ERAP Periodic Reporting Guide

Contact

First name*

Surname*

Email*

Phone

Organisation*

Message*


By sending your details, you confirm that you agree to the storing and processing of your personal data by EPAD as described in the privacy policy.


*Required


Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • The final EPAD dataset is now available to the entire research community
    2020-11-30
  • ALZFORUM
    Alzforum conference blog mentions EPAD
    2020-11-30
  • EPAD v1500 dataset
    New webpage dedicated to EPAD data and samples on the EPAD website
    2020-11-18
  • ADDI launches new Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer’s disease and related dementias
    2020-11-17
  • New paper investigating the prediction of Alzheimer’s disease biomarker status
    2020-11-12
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

Thanks Aridhia for your partnership to facilitate the latest and final @IMI_EPAD #data release. This contains the data for over 2000 participants of the EPAD Longitudinal Cohort Study. Researchers who are interested to access to this dataset can visit ep-ad.org/erap twitter.com/aridhia/status…

reply retweet favorite
1:25 pm · 2021-01-25
Twitter
EPAD
EPAD
@IMI_EPAD

We would like to thank all our followers! A massive thanks also goes to our research participants & members for all their support! Looking back on the years of the @IMI_EPAD project, here's key pictures took at major events. Have a safe & Happy New Year! youtu.be/FeYsOBOhCeo

reply retweet favorite
8:55 am · 2021-01-18
Twitter
EPAD
EPAD
@IMI_EPAD

The videos from #30AEC are online! Check out the @IMI_EPAD presentations on #data sharing by @rodrigobarnes (@aridhia) & Colin Veal (@uniofleicester). Thanks @IMI2_NEURONET and @AlzheimerEurope for giving us the opportunity to present our work. imi-neuronet.org/2020-virtual… twitter.com/IMI2_NEURONET/…

reply retweet favorite
8:43 am · 2021-01-15
Twitter
EPAD
EPAD
@IMI_EPAD

Authors investigated #data from nine studies, including @IMI_EPAD, comprising a total of 60,004 assessed participants. If you want to explore the #Alzheimer's disease data landscape, visit adata.scai.fraunhofer.de @BirkenbihlC @ApitiusHofmann @ddomingof @Simon_Lovestone @TVB_cloud

reply retweet favorite
7:56 am · 2021-01-11
Twitter
EPAD
EPAD
@IMI_EPAD

Numerous studies have collected #Alzheimer's disease cohort #data sets. @BirkenbihlC and colleagues have evaluated the Alzheimer's disease data landscape from a patient‐level data‐centric perspective. @IMI_EPAD @IMI_EMIF @NACCALZ alz-journals.onlinelibrary.wi…

reply retweet favorite
7:48 am · 2021-01-11
Copyright © 2015-19 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.